- Browse by Subject
Browsing by Subject "cancer care"
Now showing 1 - 5 of 5
Results Per Page
Sort Options
Item First Rites—A Spiritual History Case Study(AMA, 2020-01) Lion, Alex Herbert; Radiology and Imaging Sciences, School of MedicineMy patient was playing high school tennis when she noticed a painful bump on her right hand. She had heard about some players getting bone spurs, but the bump became bigger and more painful over the next few weeks. Soon it was marching band season, and she had trouble playing her trumpet. Her parents brought her to a pediatrician, who noted her symptoms of back pain, trouble breathing, and the hand mass. A chest radiographic image was taken, and she was found to have pleural effusions, fluid accumulating between the lungs and a saran wrap–like covering for the lungs (the pleura). A chest computed tomography scan was done, and the pediatrician then sent the patient to my pediatric oncology clinic.Item Global Health Equity: Cancer Care Outcome Disparities in High-, Middle-, and Low-Income Countries(American Society of Clinical Oncology, 2016-01) de Souza, Jonas A.; Hunt, Bijou; Asirwa, Fredrick Chite; Adebamowo, Clement; Lopes, Gilberto; Department of Medicine, IU School of MedicineBreakthroughs in our global fight against cancer have been achieved. However, this progress has been unequal. In low- and middle-income countries and for specific populations in high-income settings, many of these advancements are but an aspiration and hope for the future. This review will focus on health disparities in cancer within and across countries, drawing from examples in Kenya, Brazil, and the United States. Placed in context with these examples, the authors also draw basic recommendations from several initiatives and groups that are working on the issue of global cancer disparities, including the US Institute of Medicine, the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, and the Union for International Cancer Control. From increasing initiatives in basic resources in low-income countries to rapid learning systems in high-income countries, the authors argue that beyond ethics and equity issues, it makes economic sense to invest in global cancer control, especially in low- and middle-income countries.Item Gratitude in the Time of COVID(ASCO, 2020) Miller, Meagan Elizabeth; Medicine, School of MedicineItem In Search of Value in Cancer Care: What Resources Are Available to Practicing Oncologists?(2015-10) Tenner, Laura; Helft, Paul R.; Department of Medicine, IU School of MedicineItem Silver linings: a qualitative study of desirable changes to cancer care during the COVID-19 pandemic(European Institute of Oncology, 2021) Lombe, Dorothy; Sullivan, Richard; Caduff, Carlo; Ali, Zipporah; Bhoo-Pathy, Nirmala; Cleary, Jim; Jalink, Matt; Matsuda, Tomohiro; Mukherji, Deborah; Sarfati, Diana; Vanderpuye, Verna; Yusuf, Aasim; Booth, Christopher; Medicine, School of MedicineIntroduction: Public health emergencies and crises such as the current COVID-19 pandemic can accelerate innovation and place renewed focus on the value of health interventions. Capturing important lessons learnt, both positive and negative, is vital. We aimed to document the perceived positive changes (silver linings) in cancer care that emerged during the COVID-19 pandemic and identify challenges that may limit their long-term adoption. Methods: This study employed a qualitative design. Semi-structured interviews (n = 20) were conducted with key opinion leaders from 14 countries. The participants were predominantly members of the International COVID-19 and Cancer Taskforce, who convened in March 2020 to address delivery of cancer care in the context of the pandemic. The Framework Method was employed to analyse the positive changes of the pandemic with corresponding challenges to their maintenance post-pandemic. Results: Ten themes of positive changes were identified which included: value in cancer care, digital communication, convenience, inclusivity and cooperation, decentralisation of cancer care, acceleration of policy change, human interactions, hygiene practices, health awareness and promotion and systems improvement. Impediments to the scale-up of these positive changes included resource disparities and variation in legal frameworks across regions. Barriers were largely attributed to behaviours and attitudes of stakeholders. Conclusion: The COVID-19 pandemic has led to important value-based innovations and changes for better cancer care across different health systems. The challenges to maintaining/implementing these changes vary by setting. Efforts are needed to implement improved elements of care that evolved during the pandemic.